+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Pathology Market: Trends, Opportunities and Competitive Analysis 2023-2028

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Lucintel
  • ID: 5807606
The future of the global digital pathology market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The global digital pathology market is expected to reach an estimated $1,630.8 million by 2028 with a CAGR of 10.3% from 2023 to 2028. The major drivers for this market are increasing demand of digital pathology to enhance lab efficiency, growing incidence of cancer, and increasing investments in new digital pathology system by industry players across the globe.

A more than 150-page report is developed to help in your business decisions.

Digital Pathology Market by Segment

The study includes a forecast for the global digital pathology market by product, type, application, end use, and region, as follows:

Digital Pathology Market by Product [Value ($M) Shipment Analysis from 2017 to 2028]:

  • Scanners
  • Brightfield
  • Other Scanners
  • Software
  • Integrated Software
  • Standalone Software
  • Information Management Software
  • Image Analysis Software
  • Storage Systems

Digital Pathology Market by Type [Value ($M) Shipment Analysis from 2017 to 2028]:

  • Human Pathology
  • Veterinary Pathology

Digital Pathology Market by Application [Value ($M) Shipment Analysis from 2017 to 2028]:

  • Drug Discovery
  • Disease Diagnosis
  • Training & Education

Digital Pathology Market by End Use [Value ($M) Shipment Analysis from 2017 to 2028]:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Digital Pathology Market by Region [Value ($M) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Digital Pathology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital pathology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital pathology companies profiled in this report include.
  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Hamamatsu Photonics
  • F. Hoffmann-La Roche
  • 3DHISTECH
  • Apollo Enterprise Imaging
  • XIFIN
  • Visiopharm A/S
  • Aiforia Technologies Oy
  • Akoya Biosciences
  • Corista

Digital Pathology Market Insights

  • The analyst forecasts that scanners will remain the larger segment over the forecast period because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.
  • Pharmaceutical & biotechnology companies are expected to remain the largest segment due increasing use of digital pathology in various applications, such as bio banking, biopharmaceutical studies, molecular assays, and in the development of individualized medicine.
  • North America will remain the largest region due to the increasing prevalence of cancer, growing adoption of digital imaging and presence of key market players in the region.

Features of the Digital Pathology Market

  • Market Size Estimates: Digital pathology market size estimation in terms of value ($M)
  • Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Digital pathology market size by various segments, such as by product, type, application, end use, and region
  • Regional Analysis: Digital pathology market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by product, type, application, end use, and regions for the digital pathology market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the digital pathology market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQS

Q1. What is the digital pathology market size?
Answer: The global digital pathology market is expected to reach an estimated $1,630.8 million by 2028.

Q2. What is the growth forecast for digital pathology market?
Answer: The global digital pathology market is expected to grow with a CAGR of 10.3% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the digital pathology market?
Answer: The major drivers for this market are increasing demand of digital pathology to enhance lab efficiency, growing incidence of cancer, and increasing investments in new digital pathology system by industry players across the globe.

Q4. What are the major segments for digital pathology market?
Answer: The future of the digital pathology market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes.

Q5. Who are the key digital pathology companies?
Answer: Some of the key digital pathology companies are as follows:
  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Hamamatsu Photonics
  • F. Hoffmann-La Roche
  • 3DHISTECH
  • Apollo Enterprise Imaging
  • XIFIN
  • Visiopharm A/S
  • Aiforia Technologies Oy
  • Akoya Biosciences
  • Corista
Q6. Which digital pathology segment will be the largest in future?
Answer: The analyst forecasts that scanners will remain the larger segment over the forecast period because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.

Q7. In digital pathology market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to the increasing prevalence of cancer, growing adoption of digital imaging and presence of key market players in the region.

Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.

This report answers the following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the digital pathology market by product (scanners, software, and storage systems), type (human pathology and veterinary pathology), application (drug discovery, disease diagnosis, and training & education), end use (pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
2. Global Digital Pathology Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Digital Pathology Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Digital Pathology Market by Product
3.3.1: Scanners
3.3.1.1: Brightfield
3.3.1.2: Other Scanners
3.3.2: Software
3.3.2.1: Integrated Software
3.3.2.2: Standalone Software
3.3.2.2.1: Information Management Software
3.3.2.2.2: Image Analysis Software
3.3.3: Storage Systems
3.4: Global Digital Pathology Market by Type
3.4.1: Human Pathology
3.4.2: Veterinary Pathology
3.5: Global Digital Pathology Market by Application
3.5.1: Drug Discovery
3.5.2: Disease Diagnosis
3.5.3: Training & Education
3.6: Global Digital Pathology Market by End Use
3.6.1: Pharmaceutical & Biotechnology Companies
3.6.2: Hospitals and Reference Laboratories
3.6.3: Academic & Research Institutes
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Digital Pathology Market by Region
4.2: North American Digital Pathology Market
4.2.1: North American Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.2.2: North American Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.3: European Digital Pathology Market
4.3.1: European Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.3.2: European Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.4: APAC Digital Pathology Market
4.4.1: APAC Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.4.2: APAC Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
4.5: ROW Digital Pathology Market
4.5.1: ROW Digital Pathology Market by Product: Scanners, Software, and Storage Systems
4.5.2: ROW Digital Pathology Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, and Academic & Research Institutes
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Digital Pathology Market by Product
6.1.2: Growth Opportunities for the Global Digital Pathology Market by Type
6.1.3: Growth Opportunities for the Global Digital Pathology Market by Application
6.1.4: Growth Opportunities for the Global Digital Pathology Market by End Use
6.1.5: Growth Opportunities for the Global Digital Pathology Market by Region
6.2: Emerging Trends in the Global Digital Pathology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Digital Pathology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Pathology Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Leica Biosystems
7.2: Koninklijke Philips N.V.
7.3: Hamamatsu Photonics
7.4: F. Hoffmann-La Roche
7.5: 3DHISTECH
7.6: Apollo Enterprise Imaging
7.7: XIFIN
7.8: Visiopharm A/S
7.9: Aiforia Technologies Oy
7.10: Akoya Biosciences
7.11: Corista

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Leica Biosystems
  • Koninklijke Philips N.V.
  • Hamamatsu Photonics
  • F. Hoffmann-La Roche
  • 3DHISTECH
  • Apollo Enterprise Imaging
  • XIFIN
  • Visiopharm A/S
  • Aiforia Technologies Oy
  • Akoya Biosciences
  • Corista

Methodology

The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:

  • In-depth interviews of the major players in the market
  • Detailed secondary research from competitors’ financial statements and published data
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.

Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.

Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

 

Loading
LOADING...